Literature DB >> 32350509

The transcription factor ETS1 is an important regulator of human NK cell development and terminal differentiation.

Sylvie Taveirne1,2, Sigrid Wahlen1,2, Wouter Van Loocke2,3, Laura Kiekens1,2, Eva Persyn1,2, Els Van Ammel1, Katrien De Mulder1, Juliette Roels2,3, Laurentijn Tilleman4, Marc Aumercier5,6, Patrick Matthys7, Filip Van Nieuwerburgh4, Tessa C C Kerre1,2, Tom Taghon1,2, Pieter Van Vlierberghe2,3, Bart Vandekerckhove1,2, Georges Leclercq1,2.   

Abstract

Natural killer (NK) cells are important in the immune defense against tumor cells and pathogens, and they regulate other immune cells by cytokine secretion. Although murine NK cell biology has been extensively studied, knowledge about transcriptional circuitries controlling human NK cell development and maturation is limited. By generating ETS1-deficient human embryonic stem cells and by expressing the dominant-negative ETS1 p27 isoform in cord blood hematopoietic progenitor cells, we show that the transcription factor ETS1 is critically required for human NK cell differentiation. Genome-wide transcriptome analysis determined by RNA-sequencing combined with chromatin immunoprecipitation-sequencing analysis reveals that human ETS1 directly induces expression of key transcription factors that control NK cell differentiation (ie, E4BP4, TXNIP, TBET, GATA3, HOBIT, BLIMP1). In addition, ETS1 regulates expression of genes involved in apoptosis and NK cell activation. Our study provides important molecular insights into the role of ETS1 as an important regulator of human NK cell development and terminal differentiation.
© 2020 by The American Society of Hematology.

Entities:  

Year:  2020        PMID: 32350509     DOI: 10.1182/blood.2020005204

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  CGB5, INHBA and TRAJ19 Hold Prognostic Potential as Immune Genes for Patients with Gastric Cancer.

Authors:  Bei Ji; Lili Qiao; Wei Zhai
Journal:  Dig Dis Sci       Date:  2022-05-27       Impact factor: 3.199

2.  NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.

Authors:  Ti Wen; Whitney Barham; Ying Li; Henan Zhang; Joanina K Gicobi; Jacob B Hirdler; Xin Liu; Hyoungjun Ham; Kodi E Peterson Martinez; Fabrice Lucien; Roxane R Lavoie; Hu Li; Cristina Correia; Dileep D Monie; Zesheng An; Susan M Harrington; Xiaosheng Wu; Ruifeng Guo; Roxana S Dronca; Aaron S Mansfield; Yiyi Yan; Svetomir N Markovic; Sean S Park; Jie Sun; Hong Qin; Minetta C Liu; George Vasmatzis; Daniel D Billadeau; Haidong Dong
Journal:  Cancer Immunol Res       Date:  2021-12-15       Impact factor: 11.151

3.  The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency.

Authors:  Sigrid Wahlen; Filip Matthijssens; Wouter Van Loocke; Sylvie Taveirne; Laura Kiekens; Eva Persyn; Els Van Ammel; Zenzi De Vos; Stijn De Munter; Patrick Matthys; Filip Van Nieuwerburgh; Tom Taghon; Bart Vandekerckhove; Pieter Van Vlierberghe; Georges Leclercq
Journal:  Elife       Date:  2022-07-06       Impact factor: 8.713

Review 4.  Macrophage-Derived Small Extracellular Vesicles in Multiple Diseases: Biogenesis, Function, and Therapeutic Applications.

Authors:  Jingyao Ye; Xuehong Liu
Journal:  Front Cell Dev Biol       Date:  2022-06-27

5.  Scouting for common genes in the heterogenous hypoxic tumor microenvironment and their validation in glioblastoma.

Authors:  Ashish Bhushan; Ranbala Kumari; Tapasya Srivastava
Journal:  3 Biotech       Date:  2021-09-26       Impact factor: 2.893

6.  EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34+ Cells.

Authors:  Laura Damele; Adriana Amaro; Alberto Serio; Silvia Luchetti; Ulrich Pfeffer; Maria Cristina Mingari; Chiara Vitale
Journal:  Cancers (Basel)       Date:  2021-01-16       Impact factor: 6.639

7.  High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated NK cell infiltration and epithelial-mesenchymal transition in gastric cancer.

Authors:  Huafu Li; Chunming Wang; Linxiang Lan; Axel Behrens; Mona Tomaschko; Josue Ruiz; Qiao Su; Guangying Zhao; Cheng Yuan; Xing Xiao; Bo Li; Leping Yan; Wang Wu; Wuguo Li; Junzong Chen; Yulong He; Changhua Zhang
Journal:  Aging (Albany NY)       Date:  2021-02-01       Impact factor: 5.682

Review 8.  Ubiquitin-Mediated Control of ETS Transcription Factors: Roles in Cancer and Development.

Authors:  Charles Ducker; Peter E Shaw
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

Review 9.  Molecular Regulation of NK Cell Maturation.

Authors:  Jiacheng Bi; Xuefu Wang
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

10.  Transcription factor Zhx2 restricts NK cell maturation and suppresses their antitumor immunity.

Authors:  Siyu Tan; Xiaowei Guo; Mengzhen Li; Tixiao Wang; Zehua Wang; Chunyang Li; Zhuanchang Wu; Nailin Li; Lifen Gao; Xiaohong Liang; Chunhong Ma
Journal:  J Exp Med       Date:  2021-07-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.